WU Jun-wei. Clinical Evaluation on Fufang Biejia Ruangan Tablets and Mangan Jieyu Capsules for Treating Cirrhosis after Hepatitis[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(5): 327-329.
WU Jun-wei. Clinical Evaluation on Fufang Biejia Ruangan Tablets and Mangan Jieyu Capsules for Treating Cirrhosis after Hepatitis[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(5): 327-329.DOI:
Objective:To study the clinical curative effect and the influence of the life quality of Fufang Biejia Ruangan tablets (FBRT) and Mangan Jieyu capsules (MJC) for treating cirrhosis after hepatitis (compensatory period). Method: Seventy-four cases of cirrhosis after hepatitis were randomly divided into the treatment group (n=35) and the control group (n=39). Two groups were given conventional liver-protecting drugs and antiviral treatment
meanwhile the treatment group was treated by FBRT 4 tablets tid
MJC 4 capsules tid. The course of treatment was 24 weeks. Clinical symptoms
life quality
hyaluronic acid (HA)
laminin (LN)
type Ⅲ procollagen (PC Ⅲ)
type IV collagen (IV-C) were observed and determined. Result: After treatment (12
24 weeks) clinical symptoms scores in the treatment group were lower than those in control group (P<0.01). HA
LN
PC Ⅲ and IV-C in the treatment group were lower than those of the control group (P<0.05
P<0.01). The total scores in physiological
psychological and social aspects in treatment group were significantly higher than those in the control group (P<0.05
P<0.01). The effective rate was 87.18% in the treatment group
and 65.71% in the controls (P<0.05). Conclusion: For treating cirrhosis after hepatitis (compensatory period)
FBRT and MJC can obviously relieve clinical symptoms